Federation des caisses Desjardins du Quebec’s Tempest Therapeutics TPST Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$324	Hold	292	–	–	﹤0.01%	2903
2026 Q1	$479	Hold	292	–	–	﹤0.01%	2816
2025 Q4	$838	Hold	292	–	–	﹤0.01%	2693
2025 Q3	$3K	Hold	292	–	–	﹤0.01%	2550
2025 Q2	$1.99K	Hold	292	–	–	﹤0.01%	2409
2025 Q1	$2.8K	Hold	292	–	–	﹤0.01%	2279
2024 Q4	$3.17K	Buy	+292	New	+$3.77K	﹤0.01%	2169
2021 Q2	–	Hold	0	–	-$12	–	2573
2021 Q1	–	Hold	0	–	–	–	2441

Other funds holding TPST

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TPST Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Tempest Therapeutics (TPST) position steady in Q2 2026 at 292 shares worth $324. The position accounts for ﹤0.01% of the portfolio, ranked #2903.

Federation des caisses Desjardins du Quebec first reported a position in TPST in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.17K in Q4 2024. 21 funds tracked by Wall St. Rank hold TPST as of Q2 2026.

Federation des caisses Desjardins du Quebec held 292 shares of Tempest Therapeutics worth $324 as of Q2 2026.
Federation des caisses Desjardins du Quebec left its Tempest Therapeutics share count unchanged in Q2 2026.
Tempest Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2903 holding.
Federation des caisses Desjardins du Quebec first reported a position in Tempest Therapeutics in Q4 2024 and has held it in 7 quarters since.
Federation des caisses Desjardins du Quebec's Tempest Therapeutics position peaked at $3.17K in Q4 2024.
21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.